NCT07174336: A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- State
- Under way
- Phase
- Phase 3
- People
- 800 planned
- Started
- 22 Dec 2025
- Primary completion
- May 2029
- Arms
- LY4064809 + CDK4/6 Inhibitor + Endocrine Therapy (ET) (Part 1), LY4064809 + CDK4/6 Inhibitor + Endocrine Therapy (ET) (Part 2)
- Results
- None posted
- 15 Sep 2025: Trial registered
- 22 Dec 2025: Trial started